Floatz logo

[99mTc]Tc-HYNIC-FAPI

Colorectal Cancer (Locally Advanced or Metastatic)

Tomsk National Research Medical Center of the Russian Academy of SciencesPhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
89/ 100

Competitive context

839 Active assets in the Colorectal Cancer (Locally Advanced or Metastatic) cohort.

Asset / SponsorPhaseRating
Desflurane
Peter MacCallum Cancer Centre, Australia
Phase 4BBB
MARBLE DUST
James Varani
Phase 2/3BB
FLUOROURACILUM
Washington University School of Medicine
Phase 4BB
PANITUMUMAB
M.D. Anderson Cancer Center
Phase 3BB
Cetuximab
Shanghai Henlius Biotech
Phase 4BB

View all 50 →

Same molecule, other indications

[99mTc]Tc-HYNIC-FAPI is also rated in:

lung cancerDormant
CC
Indicative ·
43 / 100
View asset →
malignant pancreatic neoplasmDormant
CC
Indicative ·
43 / 100
View asset →
breast cancerDormant
CC
Indicative ·
43 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →